the impact of continous infusion adjuvants on the quality of recovery after laparoscopic bariatric surgery: dexamedetomidine versus Lidocaine.

the impact of continous infusion adjuvants on the quality of recovery after laparoscopic bariatric surgery: dexameditomidine versus Lidocaine: a double blinded randomized, placebo controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201411000927335

Enrollment

150

Registered

2014-11-04

Start date

2014-12-02

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

improving anethesia recovery quality

Interventions

dexamidetomedine group

lidocaine group

saline group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1-ASA 1 and 2 morbidly obese patients with body mass index 40 and above. 2- both male and female patients

Exclusion criteria

Exclusion criteria: 1- uncontrolled diabetes or uncontrolled hypertension. 2-allergic patients to either dexameditomedine or lidocaine 3-hepatic,renal or respiratory failure 4- smokers

Design outcomes

Primary

Measure	Time frame
quality of recovery by 40 questionaire	—

Secondary

Measure	Time frame
morphine consumption	—

Countries

Egypt

Contacts

Public ContactHazem Elsersy

Lecturer of Anethesia, Faculty of medicine,Menoufia University

hazelsersy@hotmail.com00201091096655

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026